Category: Intellectual property
-
Galapagos Licensing Inflammation Drug in $2.1B Deal
17 December 2015. A biotechnology company is licensing its small molecule drug for treating inflammatory disorders to the biopharmaceutical company Gilead Sciences in a deal valued at nearly $2.1 billion. The agreement includes Gilead Sciences taking an ownership stake in Galapagos NV, based in Mechelin, Belgium. The deal involves the small-molecule, or low molecular weight,…
-
Exosome Therapy Start-Up Launches, Raises $80M
17 November 2015. A new biotechnology company developing therapies that use tiny cellular containers to deliver their payloads is spun off from M.D. Anderson Cancer Center and raising $80 million in early venture funding. Codiak Biosciences, based in Cambridge, Massachusetts is founded and licensing research by Raghu Kalluri, chair of M.D. Anderson’s cancer biology department.…
-
Licensing, Research Deal Aims at Chronic Wound Treatments
16 November 2015. Umeå University and the pharmaceutical company Prometic are partnering on development of new treatments for chronic wounds, such as diabetic foot ulcers and bed sores. The agreement gives Prometic, in Laval, Quebec, Canada an exclusive license to the university’s research on the blood plasma protein plasminogen, with the company funding further studies…
-
Start-Up’s Air Quality Technology to Clean City Areas
10 November 2015. A start-up company is licensing research from University of Copenhagen in Denmark to develop a technology for removing air pollution from city neighborhoods. The air cleaning technology, known as gas phase advanced oxidation, is a product of the atmospheric chemistry lab led by Matthew Johnson, who also serves as chief scientist for…
-
Biotech, Accelerator to Partner on Glaucoma Treatment
30 October 2015. A new eye-drop treatment for the underlying causes of glaucoma is being developed in a collaboration between a biotechnology enterprise spun-off from Northwestern University and a company that acquires biomedical research assets. Financial aspects of the deal between Mannin Research Inc. in Toronto, Ontario, Canada and Q BioMed Inc. in New York…
-
Gene Editing Licensed for Inherited Disease Treatments
26 October 2015. A Boston biotechnology company is licensing gene-editing technologies from a nearby start-up to design treatments for cystic fibrosis and inherited blood disorders, including sickle cell disease. Vertex Pharmaceuticals, in Boston, received rights to techniques known as CRISPR-Cas9 in a deal that could bring CRISPR Therapeutics, founded in April 2014, as much as…
-
Novartis Licensing Depression Therapy Technology
19 October 2015. Luc Therapeutics, a biotechnology company designing treatments for psychiatric and neurological disorders, is licensing part of its technology to the pharmaceutical company Novartis to develop treatments for depression. Dollar amounts paid under the agreement to Luc Therapeutics, in Cambridge, Massachusetts, were not disclosed. Depression is a widespread condition, which when it becomes…
-
Cancer Institute Spins-Off Company, Gains Licensing Deal
14 October 2015. Ontario Institute for Cancer Research is spinning off a new enterprise to discover therapies for blood-related cancers, and will partner with Janssen Biotech Inc. to take those therapies to market. The licensing deal between Novera Therapeutics Inc., the OICR spin-off company in Toronto, and Janssen Biotech, a division of Johnson & Johnson,…
-
Spin-Off to Provide Lower-Cost Molecular Imaging Technology
13 October 2015. A new enterprise based on research at Harvard University is offering a technology that allows ordinary microscopes to display high resolution images of single molecules. The company, Ultivue Inc., is founded by and licensing technologies from the lab of Peng Yin at Harvard’s Wyss Institute for Biologically Inspired Engineering. Yin and colleagues…
-
Patent Awarded for Slower Digested Wheat
12 October 2015. A type of wheat digested more slowly than regular wheat, and thus releases glucose more slowly into the blood stream, received a patent from the U.S. Patent and Trademark Office. Patent number 9,150,839, titled “Wheat with increased resistant starch levels ,” was awarded on 2 October to four inventors and assigned to…